Table 4.
mean and median laboratory findings of the COVID-19 patients admitted to Mengo Hospital Treatment Unit from December 2020 to August 2021 (N=314)
| Variable | Mean ± SD or median (IQR) |
|---|---|
| White blood count, x109/l | 8.83 (6.06-12) |
| Neutrophil count, x109/l | 6.83 (4.08-10.31) |
| Lymphocyte count, x109/l | 1.1 (0.84-1.48) |
| Platelet count, x109/l | 207.5 (159-283) |
| Fasting blood glucose, mmol/l | 10.35 (7.5-16.2) |
| Glycated hemoglobin, % | 6.5 (4.8 - 9.1) |
| D-dimers, mg/l | 1.46 (0.65 - 3.54) |
| C-reactive protein, mg/dl | 14.98 (7.8 - 29) |
| Erythrocyte sedimentation rate, ml/min | 45 (18 - 70) |
| Sodium, mmol/l | 135 (132 - 138) |
| Potassium, mmol/l | 4.6 (4.14-4.98) |
| Creatinine, mmol/l | 89.6 (71 - 118) |
| Total bilirubin, µmol/l | 7.15 (5 - 13.8) |
| Alanine amino transaminase, IU/L | 33 (22.7-50.7) |
| Aspartate amino transaminase, IU/L | 39 (28-67.6) |
| Alkaline phosphatase, IU/L | 112 (85-138) |
| ƴ-glutamyl transpeptidase, IU/L | 60 (38-98) |
| Total cholesterol, mmol/l | 5.325 (4.2 - 6.28) |
| High density lipoprotein cholesterol, mmol/l | 1.08 ± 0.84 |
| Low density lipoprotein cholesterol, mmol/l | 3.928 ± 1.0418 |
| Non-high-density lipoprotein cholesterol, mmol/l | 4.25 (3 - 5.13) |
| Triglycerides, mmol/l | 2.04 (1.58 - 2.9) |
| Triglyceride glucose index | 9.76 (9.29 - 10.33) |
SD: standard deviation; IQR: interquartile range